- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CAD pioneer partners with Sectra
R2 Technology and Swedish IT and medical technology company Sectra Imtec are customizing R2's computer-aided detection technology for use with the Sectra MicroDose digital mammography system. The focus of the agreement is R2's ImageChecker CAD
R2 Technology and Swedish IT and medical technology company Sectra Imtec are customizing R2's computer-aided detection technology for use with the Sectra MicroDose digital mammography system. The focus of the agreement is R2's ImageChecker CAD technology, which is designed to assist radiologists in the early detection of breast cancer and has already been incorporated into digital mammography systems from other vendors, including GE Medical Systems. The two companies plan to integrate CAD not only into the MicroDose mammography system but also into Sectra PACS for Breast Imaging. Under the agreement, Sectra will have exclusive worldwide distribution rights for three years to R2's CAD technology as applied to Sectra's MicroDose mammography system. The system is based on a highly efficient digital detector technology, which promises to reduce radiation dose by 80% or more without affecting image quality. Sectra recently invested more than $11 million in Stockholm-based Mamea Imaging, developer of the novel detector technology and ergonomic imaging stand that make up Sectra's low-dose digital mammography system (SCAN 1/8/04).
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
